Predictive Significance of a New Prognostic Score for Patients With Diffuse Large B-Cell Lymphoma in the Interim-Positron Emission Tomography Findings-Reference-Cited by-同舟云学术

Predictive Significance of a New Prognostic Score for Patients With Diffuse Large B-Cell Lymphoma in the Interim-Positron Emission Tomography Findings

Published:2016-02 Issue:6 Volume:95 Page:e2808
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Kong Yu,Qu Lili,Li Yuekai,Liu Dai,Lv Xuemin,Han Jiankui

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference26 articles.

1. Treatment challenges in the management of relapsed or refractory non-Hodgkin's lymphoma—novel and emerging therapies;Chao;Cancer Manag Res,2013

2. Rituximab and ICE as second-line therapy before autologous stem cell transplantation for relapsed or primary refractory diffuse large B-cell lymphoma;Kewalramani;Blood,2004

3. [18F] fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in aggressive lymphoma: an early prognostic tool for predicting patient outcome;Haioun;Blood,2005

4. A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project;Shipp;N Engl J Med,1993

5. The use of interim 18F-fluorodeoxyglucose PET to guide therapy in lymphoma;Araf;Future Oncol,2013

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Challenges identifying DLBCL patients with poor outcomes to upfront chemoimmunotherapy and its impact on frontline clinical trials;Leukemia & Lymphoma;2024-01-05

2. Efficacy of Residual Site Radiation Therapy (ISRT) in Patients with Primary Mediastinal Lymphoma with Deauville Score 4 Following R-CHT: Results of a Retrospective Mono Institutional Study;Journal of Clinical Medicine;2023-05-31

3. The value of FDG PET/CT imaging in outcome prediction and response assessment of lymphoma patients treated with immunotherapy: a meta-analysis and systematic review;European Journal of Nuclear Medicine and Molecular Imaging;2022-08-06

4. Ki67 Immunohistochemical Expression Level ≥70%, Bulky Presentation ≥7.5 cm, Meningeal Lymphomatosis, and Interim PET ΔSUVmax After 4 Treatment Cycles <71% as Parts of a Practical Scoring System to Predict Progression-Free Survival and Overall Survival in Diffuse Large B-Cell Lymphoma;Frontiers in Nuclear Medicine;2022-04-07

5. Risk Stratification for Diffuse Large B-Cell Lymphoma by Integrating Interim Evaluation and International Prognostic Index: A Multicenter Retrospective Study;Frontiers in Oncology;2021-12-16